Blueprint Medicines Corp·4

Jun 23, 7:05 PM ET

Tsai John 4

4 · Blueprint Medicines Corp · Filed Jun 23, 2023

Insider Transaction Report

Form 4
Period: 2023-06-21
Tsai John
Director
Transactions
  • Award

    Common Stock

    2023-06-21+2,6006,500 total
  • Award

    Stock Option (Right to Buy)

    2023-06-21+5,3005,300 total
    Exercise: $63.66Exp: 2033-06-21Common Stock (5,300 underlying)
Footnotes (2)
  • [F1]The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) June 21, 2024 and (ii) the next annual meeting of the Issuer's stockholders. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]This option vests with respect to 100% of the shares underlying the option on the earlier of (i) June 21, 2024 and (ii) the next annual meeting of the Issuer's stockholders.

Documents

2 files